A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

Bibliographic Details
Main Authors: Chavan, Sushant V., Chavan, Niraj R., Balaji, Anusha, Trivedi, Vatsala D., Chavan, Padma R.
Format: Online
Language:English
Published: Medknow Publications & Media Pvt Ltd 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237243/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237243/

Similar Items